Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
277.00    -12.00 (-4.15%)
Bid:
275.00
Ask:
279.00
Spread: 4.00 (1.455%)
Market Cap: £248.99m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Directorate Changes

11 Mar 2020 07:00

RNS Number : 6727F
Norcros PLC
11 March 2020
 

Norcros plc

("Norcros" or "the Company")

Directorate Changes

Norcros plc, a market leading supplier of high quality and innovative bathroom and kitchen products announces the appointment with effect from 1 May 2020 of Mark Allen OBE to the Board as Non-Executive Director and Board Chair designate.

Norcros also announces that, in line with best practice, after nearly nine years on the board Martin Towers will be stepping down as a Non-Executive Director and Board Chair. Martin will continue in office until the 2020 AGM of Norcros plc in July and will not seek re-election then, when Mark will seek election as a director and, subject to that, take over as Board Chair.

Mark Allen spent the majority of his executive career at Dairy Crest plc, where he was CEO from 2006 until 2019. He is currently a non-executive director of Warburtons Limited, and from 2011 to 2019 was a non-executive director of Howden Joinery Group plc. Previously he was also the Chair of Dairy UK Ltd, the trade body of the dairy industry.

Commenting on these changes, David McKeith, Senior Independent Director, said "I am delighted to welcome Mark Allen as a non-executive director of Norcros plc. His broad range of skills and experience will be of significant benefit to the Board. The Board and I very much look forward to working with him over the coming years." 

"Nick Kelsall and I would also like to put on record the Board's appreciation of Martin Towers' valued contribution as a non-executive director of Norcros since 2011. As Board Chair from November 2012, Martin has steered the Company through a period of considerable change, and profitable growth."

There are no disclosures concerning Mark Allen to be made under Listing Rule 9.6.13 other than his other directorships referred to in this announcement.

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

David McKeith, Senior Independent Director

 

 

 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAJMMFTMTIBBFM
Date   Source Headline
22nd Jul 20244:06 pmRNSDirector Dealings - APSP Share Option exercises
19th Jul 202410:36 amRNSTotal Voting Rights
2nd Jul 20241:51 pmRNSHolding(s) in Company
1st Jul 202412:53 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSDirector Declaration
21st Jun 20247:00 amRNSAnnual Financial Report and Notice of 2024 AGM
18th Jun 20243:50 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSResults for the year ended 31 March 2024
31st May 20247:00 amRNSTotal Voting Rights
30th May 20244:15 pmRNSHolding(s) in Company
24th May 20247:00 amRNSAppointment of Independent Non-Executive Director
23rd May 20247:30 amRNSDirector Declaration
20th May 20247:00 amRNSSale of Johnson Tiles UK
7th May 20247:00 amRNSNorcros business wins King's Award for Enterprise
1st May 202410:52 amRNSVoting Rights and Share Capital Update
1st May 20247:00 amRNSCapital Markets Event
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.